Chimeric Therapeutics Ltd Health Care
Biotech Cancer Healthcare

$0.038 0.001 (2.70%)

High $0.04	Low $0.04	Trades 17	Turnover $72,787	Volume 1,963,571
30 June 2023 at 3:59pm

Please note that we source our information from many sources. The below may not be accurate, or up to date. Please bear with us whilst we fine tune our data collection. In the meantime, we do not recommend relying on the below. It is merely a guide!

Stock Information

Code CHM	Name Chimeric Therapeutics Ltd	Country AU	Currency AUD
GIC Sector Health Care	GIC Group Pharmaceuticals, Biotechnology & Life Sciences	GIC Industry Biotechnology	GIC Sub Industry Biotechnology
Sector Healthcare	IPO Date N/A	Fiscal Year June	Type Common Stock
Shares Outstanding 95,906,427	Shares Floated 37,564,251	Held by Insiders 21.119%	Held by Institutions 1.813%

Directors & Officers

Name & Education	Position
Dr. Rebecca McQualter	Chief Executive Officer
Mr. Aaron Laurita	Chief Financial Officer
Dr. Stephanie H. Astrow MBA, Ph.D.	Chief Scientific Officer
Dr. Agathe Bourgogne	Head of Manufacturing
Mr. Nathan Jong C.A.	Joint Company Secretary

CHM Historic Dividends

Date	Amount
We found no dividends on record for CHM.

End of Day Prices

Date	Close	Volume	Change
15-Sep	$0.01	21,448	0.00 (14.29%)
14-Sep	$0.01	67,857	0.00 (12.50%)
11-Sep	$0.01	108,734	0.00 (0.00%)
10-Sep	$0.01	66,240	+0.00 (14.29%)
09-Sep	$0.01	1,231,577	0.00 (0.00%)
08-Sep	$0.01	1,760,880	+0.00 (16.67%)
07-Sep	$0.01	5,329,283	0.00 (25.00%)
04-Sep	$0.01	3,354,346	0.00 (27.27%)
03-Sep	$0.01	2,858	0.00 (8.33%)
02-Sep	$0.01	17,546	0.00 (0.00%)
01-Sep	$0.01	43,133	+0.00 (9.09%)
31-Aug	$0.01	2,033,701	+0.00 (22.22%)
28-Aug	$0.01	5,414,073	0.00 (10.00%)
27-Aug	$0.01	2,011,389	0.00 (9.09%)
26-Aug	$0.01	1,873,645	0.00 (15.38%)
4 up, 8 down, and 3 flat days

Market Cap (15-Sep) $575,438	EBITDA -	PE 0.00	Book Value $-0.14
Dividend per Share N/A	Dividend Yield N/A	EPS $-0.61	Profit Margin N/A
Operating Margin 258.99%	ROA 46.75%	ROE 1290.99%	Revenue (FY) -
Revenue per Share -	Gross Profit (FY) $-189,845	Q' YOY Revenue Growth 52.8%	Q' YOY Earnings Growth -

Chimeric Therapeutics Ltd Health Care
Biotech Cancer Healthcare

Stock Information

Technicals

Financial Snapshot (June 2026)

Directors & Officers

CHM Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Chimeric Therapeutics Ltd Health Care Biotech Cancer Healthcare

Stock Information

Technicals

Financial Snapshot (June 2026)

Directors & Officers

CHM Historic Dividends

Followers

Prices

Announcements

End of Day Prices

Chimeric Therapeutics Ltd Health Care
Biotech Cancer Healthcare